Richmond biotech BrainBox Solutions Inc., the maker of an artificial intelligence-enabled concussion test, has been awarded a $3.5 million grant from the National Institute of Neurological Disorders and Stroke to support the development of a diagnostic tool for concussions and cognitive impairment in the elderly.
The new tool, called BrainBox Geriatrics, integrates blood biomarkers with other tests to enable rapid diagnosis and prognosis with a single device at a patient’s bedside. The technology builds upon BrainBox’s traumatic brain injury test for adults, which is currently undergoing clinical trials.
The grant money will support the development of the tool as well as clinical tests, and BrainBox is teaming with Roanoke’s Carilion Clinic and the University of Pennsylvania on the funding and trials.
The company said the new tool fills a critical need, as there are currently no tests that can accurately diagnose or predict outcomes for geriatric patients with mild traumatic…
Read the full story from the Washington Business Journal.
